Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opioid Receptors in Brain Following Oral Dosing
Clinical trial NCT05547542 · COMPLETED
Trial details
- NCT number
- NCT05547542
- Sponsor
- Cerevel Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-02
- Primary completion
- 2024-07-24
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.